Skip to main content

Advertisement

SpringerLink
Log in

Oleosomes Encapsulating Sildenafil Citrate as Potential Topical Nanotherapy for Palmar Plantar Erythrodysesthesia with High Ex vivo Permeation and Deposition

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Palmar plantar erythrodysesthesia (PPE) is a commonly reported skin toxicity of chemotherapeutic agents that significantly affects patients’ quality of life. PPE is described as inflammation, swelling, and even cracks and ulcers in the skin of palms and soles of the feet. Conventional treatment includes topical creams, analgesics, or corticosteroids. However, serious cases are not responding to these medications. PPE has been reported to cause drug cessation or dose reduction if not properly treated. Sildenafil citrate (SC) has a well-documented activity in wound healing through improving blood supply to the affected area. However, SC has poor physicochemical properties limiting its transdermal permeation and deposition. This research endeavored to elaborate novel vesicular system with natural components, phospholipids and oleic acid, loaded with sildenafil citrate for topical management of PPE. Sildenafil-loaded oleosomes were prepared using modified ethanol injection method. Optimized oleosomes had nanometric particle size (157.6 nm), negative zeta potential (− 85.2 mv), and high entrapment efficiency (95.56%). Ex vivo studies on human skin revealed that oleosomes displayed 2.3-folds higher permeation and 4.5-folds more deposition through the human skin compared to drug suspension. Results endorsed SC oleosomes as suitable topical treatment of PPE providing ameliorated sildenafil permeability in addition to acting as a reservoir for gradual release of the drug.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Baack BR, Burgdorf WH. Chemotherapy-induced acral erythema. J Am Acad Dermatol. 1991;24(3):457–61.

    CAS  PubMed  Google Scholar 

  2. Urakawa R, Tarutani M, Kubota K, Uejima E. Hand foot syndrome has the strongest impact on QOL in skin toxicities of chemotherapy. J Cancer. 2019;10(20):4846–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Ratain MJ, Eisen T, Stadler WM, Flaherty KT, Kaye SB, Rosner GL, et al. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol. 2006;24(16):2505–12.

    CAS  PubMed  Google Scholar 

  4. Keshishyan S, Sehdev V, Reeves D, Ray SD. Cytostatic agents. In: A worldwide yearly survey of new data in adverse drug reactions [Internet]. 1st ed. Elsevier B.V.; 2015. p. 567–81. Available from: https://doi.org/10.1016/bs.seda.2015.08.009

  5. Lacouture M, Reilly L, Gerami P, Guitart J. Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib. Ann Oncol. 2008;19(11):1955–61.

    CAS  PubMed  Google Scholar 

  6. Ishak R, Aad S, Kyei A, Farhat F. Cutaneous manifestations of antiangiogenic therapy in oncology: review with focus on VEGF inhibitors. Crit Rev Oncol Hematol. 2014;90(2):152–64.

    PubMed  Google Scholar 

  7. Nikolaou V, Syrigos K, Saif MW. Incidence and implications of chemotherapy related hand-foot syndrome. Expert Opinion on Drug Safety [Internet]. 2016;15(12):1625–33. Available from: https://doi.org/10.1080/14740338.2016.1238067

  8. Daher IN, Yeh ET. Vascular complications of selected cancer therapies. Nat Rev Cardiol. 2008;5:797–805.

    CAS  Google Scholar 

  9. Frankfurt P, Goethe-universita KDJW. Nitric oxide drives skin repair : novel functions of an established mediator. Kidney Int. 2002;61:882–8.

    Google Scholar 

  10. Denningera J, Marletta M. Guanylate cyclase and the NO/cGMP signaling pathway. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1999;1411(2–3):334–50.

    Google Scholar 

  11. Ghofrani HA, Osterloh IH, Grimminger F. Sildenafil : from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov. 2006;5(8):689–702.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Salcido R. Viagra and wound healing: the NO connection. Adv Skin Wound Care. 2008;21(3):106–8.

    PubMed  Google Scholar 

  13. Colglazier C, Sutej P, O’Rourke K. Severe refractory fingertip ulcerations in a patient with scleroderma: successful treatment with sildenafil. J Rheumatol. 2005;32(12):2440–2.

    PubMed  Google Scholar 

  14. Meadows KL, Rushing C, Honeycutt W, Latta K, Arrowood CA, Niedzwiecki D, et al. Treatment of palmar plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study. Support Care Cancer. 2015;23(5):1311–9.

    PubMed  Google Scholar 

  15. Kamboj S, Saini V, Maggon N, Bala S, Jhawat V. Vesicular drug delivery systems: a novel approach for drug targeting. Int J Drug Deliv. 2013;5(2):121–30.

    Google Scholar 

  16. Gregoriadis G, Florence AT. Liposomes in drug delivery. Drugs. 1993;45(1):15–28.

    CAS  PubMed  Google Scholar 

  17. Roncero J, Álvarez-Ortí M, Pardo A. Virgin almond oil: extraction methods and composition. Grasas Aceites. 2016;67(3):1–9.

    Google Scholar 

  18. Tvrzicka E, Kremmyda L, Stankova B, Zak A. Fatty acids as biocompounds: their role in human metabolism, health and disease--a review. Part 1: classification, dietary sources and biological functions. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(2):117–30.

    CAS  PubMed  Google Scholar 

  19. Zakir F, Vaidya B, Goyal AK, Malik B, Vyas P, Zakir F, et al. Development and characterization of oleic acid vesicles for the topical delivery of fluconazole. Drug Deliv. 2010;17(4):238–48.

    CAS  PubMed  Google Scholar 

  20. Schopf N, Camila P, Mailine C, Laura G, Giuliani M, Trivisiol D, et al. Oleic acid - containing semisolid dosage forms exhibit in vivo anti-inflammatory effect via glucocorticoid receptor in a UVB radiation-induced skin inflammation model. Inflammopharmacology [Internet]. 2019;2–14. Available from: https://doi.org/10.1007/s10787-019-00675-5

  21. Huang C, Chen C, Pornpattananangkul D, Zhang L, Chan M, Hsieh M, et al. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials. 2011;32:214–21.

    CAS  PubMed  Google Scholar 

  22. Bragagni M, Mennini N, Maestrelli F, Cirri M, Mura P. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib. Drug Deliv. 2012;19(7):354–61.

    CAS  PubMed  Google Scholar 

  23. Abdulbaqi IM, Darwis Y, Nurzalina Abdul Karim Khan RAA, Khan AA. Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomedicine. 2016;11:2279–304.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Song CK, Balakrishnan P, Shim C, Chung S, Chong S, Kim D. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B: Biointerfaces. 2012;92:299–304.

    CAS  PubMed  Google Scholar 

  25. Elnaggar YS, El-Massik MA, Abdallah OY. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Int J Nanomedicine. 2011;6:3195–205.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Elnaggar YS, El-massik M, Abdallah OY. Sildenafil citrate nanoemulsion vs. self-nanoemulsifying delivery systems: rational development and transdermal permeation. Int J Nanotechnol. 2011;8(8–9):749–63.

    CAS  Google Scholar 

  27. Elsheikh MA, Elnaggar YSR, Hamdy DA, Abdallah OY. Novel cremochylomicrons for improved oral bioavailability of the antineoplastic phytomedicine berberine chloride: optimization and pharmacokinetics. Int J Pharm. 2018;535(1–2):316–24.

    CAS  PubMed  Google Scholar 

  28. Elnaggar YSR, Omran S, Hazzah HA, Abdallah OY. Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate. Int J Pharm. 2019;564:410–25.

    CAS  PubMed  Google Scholar 

  29. Daraghmeh N, Omari M Al, Pharmaceutical J, Company M, Badwan AA, Abdel-motalleb J. Determination of sildenafil citrate and related substances in the commercial products and tablet dosage form using HPLC. J Pharm Biomed Anal 2001;25(3–4):483–492.

  30. OECD Guidelines for the testing of chemicals; skin absorption: in vitro method. 2011.

    Google Scholar 

  31. Benech-Kieffer F. Guidelines for percutaneous absorption/penetration. 1997.

    Google Scholar 

  32. Abd E, Yousef SA, Pastore MN, Telaprolu K, Mohammed YH, Namjoshi S, et al. Skin models for the testing of transdermal drugs. Clin Pharmacol. 2016;8:163–76.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Dreher F, Fouchard F, Patouillet C, Andrian M, Simonnet J, Benech-kieffer F. Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or alpha-tocopherol applied on human skin models or human skin ex vivo at finite doses. Skin Pharmacol Appl Ski Physiol. 2002;15(suppl 1):40–58.

    CAS  Google Scholar 

  34. Richard YH, Nojima K, Adams WP, Brown SA. Analysis of facial skin thickness: defining the relative thickness index. Plast Reconstr Surg. 2004;115(6):1769–73.

    Google Scholar 

  35. Godin B, Touitou E. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev. 2007;59(11):1152–61.

    CAS  PubMed  Google Scholar 

  36. Bhadra S, Das SC, Roy S, Arefeen S, Rouf ASS. Development and validation of RP-HPLC method for quantitative estimation of vinpocetine in pure and pharmaceutical dosage forms. Chromatogr Res Int. 2011;2011:1–7.

    Google Scholar 

  37. Elnaggar YS, Talaat SM, Bahey-El-Din M, Abdallah OY. Novel lecithin-integrated liquid crystalline nanogels for enhanced cutaneous targeting of terconazole: development, in vitro and in vivo studies. Int J Nanomedicine. 2016;11:5531–47.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Butani DV, Yewale CP, Misra A. Amphotericin B topical microemulsion: formulation, characterization and evaluation. Colloids Surf B: Biointerfaces. 2014;116:351–8.

    CAS  PubMed  Google Scholar 

  39. Verma S, Bhardwaj A, Mohit V, Bajpai P, Goutam N, Kumar L. Oleic acid vesicles: a new approach for topical delivery of antifungal agent. Artif Cell Blood Sub Biotechnol. 2014;42(2):95–101.

    CAS  Google Scholar 

  40. Akomeah FK, Martin GP, Brown MB. Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties. J Pharm Sci. 2007;96(4):824–34.

    CAS  PubMed  Google Scholar 

  41. Guth K, Schäfer-korting M, Fabian E, Landsiedel R, Van Ravenzwaay B. Suitability of skin integrity tests for dermal absorption studies in vitro. Toxicol in Vitro. 2015;29(1):113–23.

    CAS  PubMed  Google Scholar 

  42. Batzri S, Korn ED. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta. 1973;298(4):1015–9.

    CAS  PubMed  Google Scholar 

  43. Stano P, Bufali S, Pisano C, Bucci F, Barbarino M, Santaniello M, et al. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method. J Liposome Res. 2004;14(1–2):87–109.

    CAS  PubMed  Google Scholar 

  44. Staggers JE, Hernell O, Stafford RJ, Carey MC. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption 1. Phase-behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human-beings. Biochemistry. 1990;29(8):2028–40.

    CAS  PubMed  Google Scholar 

  45. Wang Y, Chow MSS, Zuo Z. Mechanistic analysis of pH-dependent solubility and trans-membrane permeability of amphoteric compounds: application to sildenafil. Int J Pharm. 2008;352(1–2):217–24.

    CAS  PubMed  Google Scholar 

  46. Gobry V, Bouchard G, Carrupt P-A, Testa B, Girault HH. Physicochemical characterization of sildenafil: ionization, lipophilicity behavior and ionic-partition diagram studied by two-phase titration and electrochemistry. Helvetica Chimica Acta. 2000;83(7):1465–74.

    CAS  Google Scholar 

  47. Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine. 2012;8(2):237–49.

    CAS  PubMed  Google Scholar 

  48. Shaji J, Garude S. Development and characterization of ketorolac tromethamine encapsulated transethosomes for enhanced transdermal delivery. World Int J Pharm Pharm Sci. 2014;3(9):1213–27.

    Google Scholar 

  49. Rowat AC, Kitson N, Thewalt JL. Interactions of oleic acid and model stratum corneum membranes as seen by 2 H NMR. Int J Pharm. 2006;307(2):225–31.

    CAS  PubMed  Google Scholar 

  50. Darshan T, Nirgulkar M, Umekar S, Patil A, Anil P, Bali N. Enhanced transdermal permeation and anti-inflammatory potential of phospholipids complex-loaded matrix film of umbelliferone: formulation development, physico-chemical and functional characterization. Eur J Pharm Sci. 2019;131:23–38.

    Google Scholar 

  51. Yokomizo Y. Effects of phospholipids on the percutaneous penetration of drugs through the dorsal skin of the guinea pig, in vitro. 3. The effects of phospholipids on several drugs having different polarities. J Control Release. 1996;42(3):217–28.

    CAS  Google Scholar 

  52. Elsheikh MA, Elnaggar YSR, Abdallah OY. Rationale employment of cell culture versus conventional techniques in pharmaceutical appraisal of nanocarriers. J Control Release. 2014;194:92–102.

    CAS  PubMed  Google Scholar 

  53. Akula P, Lakshmi PK. Effect of pH on weakly acidic and basic model drugs and determination of their ex vivo transdermal permeation routes. Braz J Pharm Sci. 2018;54(2):1–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Pharos University in Alexandria., Mahmoudia Street, beside Green Plaza Complex, Alexandria, Egypt

    Lamiaa R. Abdelalim

  2. Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt

    Yosra S. R. Elnaggar

  3. Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt

    Yosra S. R. Elnaggar & Ossama Y. Abdallah

Authors
  1. Lamiaa R. Abdelalim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yosra S. R. Elnaggar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ossama Y. Abdallah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lamiaa R. Abdelalim.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdelalim, L.R., Elnaggar, Y.S.R. & Abdallah, O.Y. Oleosomes Encapsulating Sildenafil Citrate as Potential Topical Nanotherapy for Palmar Plantar Erythrodysesthesia with High Ex vivo Permeation and Deposition. AAPS PharmSciTech 21, 310 (2020). https://doi.org/10.1208/s12249-020-01862-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/s12249-020-01862-2

Key Words

Search

Navigation